Jefferies Financial Group Inc. Invests $2.45 Million in LeMaitre Vascular, Inc. $LMAT

Jefferies Financial Group Inc. purchased a new position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 25,537 shares of the medical instruments supplier’s stock, valued at approximately $2,451,000. Jefferies Financial Group Inc. owned about 0.11% of LeMaitre Vascular as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund lifted its holdings in shares of LeMaitre Vascular by 1.1% in the fourth quarter. Illinois Municipal Retirement Fund now owns 11,171 shares of the medical instruments supplier’s stock valued at $906,000 after purchasing an additional 123 shares in the last quarter. NewEdge Advisors LLC increased its stake in LeMaitre Vascular by 4.6% during the 4th quarter. NewEdge Advisors LLC now owns 3,158 shares of the medical instruments supplier’s stock worth $256,000 after buying an additional 139 shares during the period. Federated Hermes Inc. grew its holdings in LeMaitre Vascular by 0.4% during the 2nd quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier’s stock worth $3,294,000 after acquiring an additional 155 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in shares of LeMaitre Vascular by 5.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 3,259 shares of the medical instruments supplier’s stock valued at $356,000 after acquiring an additional 169 shares during the last quarter. Finally, Sound Income Strategies LLC lifted its holdings in LeMaitre Vascular by 425.6% in the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock worth $25,000 after acquiring an additional 183 shares during the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on LMAT shares. Citizens Jmp raised their price target on shares of LeMaitre Vascular from $118.00 to $127.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 6th. Weiss Ratings lowered shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, August 14th. Zacks Research cut shares of LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Wall Street Zen cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Barrington Research lowered LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 5th. Three research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $110.60.

LeMaitre Vascular Stock Performance

NASDAQ:LMAT opened at $80.45 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 13.96 and a current ratio of 16.31. The firm’s 50-day moving average is $93.04 and its 200-day moving average is $99.32. LeMaitre Vascular, Inc. has a 52-week low of $78.27 and a 52-week high of $118.01. The company has a market cap of $1.84 billion, a price-to-earnings ratio of 28.23, a PEG ratio of 2.32 and a beta of 0.53.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.07). The firm had revenue of $70.38 million for the quarter, compared to the consensus estimate of $71.47 million. LeMaitre Vascular had a net margin of 25.02% and a return on equity of 15.63%. The company’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.60 earnings per share. Equities research analysts anticipate that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current year.

LeMaitre Vascular Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a dividend of $0.25 per share. The ex-dividend date is Thursday, August 20th. This represents a $1.00 dividend on an annualized basis and a yield of 1.2%. LeMaitre Vascular’s dividend payout ratio is 35.09%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.